Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Acquisitions (Tables)

v3.22.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about business combination [abstract]  
Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination
The acquisition-date fair value of Higi has been allocated on a preliminary basis as follows:

Recognized values on acquisition
$‘000
Carrying value of existing equity interest
11,274 
Gain on remeasurement of existing equity interest 10,495 
Fair value of non-controlling interest 64,274 
Acquisition date fair value of Higi 86,043 
Accounts receivable 2,314 
Property, plant and equipment 17,618 
License arrangements 2,650 
Trade names 3,100 
Developed technology 5,900 
Deferred tax liability (730)
Other assets and liabilities, net (5,983)
Net assets acquired
24,869 
Goodwill
61,174 
The estimated fair value of assets acquired as of the acquisition date were as follows:
Recognized values on acquisition
$‘000
Cash paid, net of cash acquired
13,798 
Issuance of warrants
2,349 
Aggregate purchase price 16,147 
Accounts receivable 751 
Customer relationships 11,600 
Physician’s network 3,500 
Trademark 1,900 
License 590 
Claims payable
(13,436)
Deferred tax liability (2,610)
Other assets and liabilities, net
(817)
Net assets acquired
1,478 
Goodwill
14,669 
The fair value of assets acquired as of the acquisition date were as follows:
Recognized values on acquisition
$‘000
Acquiree’s net assets at the acquisition date:
Intangible assets
7,900 
Right-of-use asset
153 
Lease liability
(153)
Net identifiable assets and liabilities
7,900 
Goodwill
17,771 
Consideration paid
25,671